Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93

Jinling Huang,Hae-youn Lee,Xiaohong Zhao,Jinyi Han,Yang Su,Qinli Sun,Jing Shao,Jiwan Ge,Yuxi Zhao,Xue Bai,Yi He,Xinquan Wang,Xiaohu Wang,Chen Dong

DOI: https://doi.org/10.1016/j.immuni.2021.03.018

IF: 32.4

2021-01-01

Immunity

Abstract:The interleukin (IL)-17 family, consisting of six members, promotes host defense but can in some context promote the development of autoimmune disease. Here, we examined the role of IL-17D, a poorly understood member in the IL-17 family. IL-17D was expressed primarily by colonic epithelial cells. Il17d(-/-) mice were more susceptible to acute colitis, bacterial infection and experimentally induced colon cancer than their wild-type counterparts. Il17d deficiency impaired IL-22 production by group 3 innate lymphoid cells (ILC3s) and reduced expression of IL-22-dependent antimicrobial peptides, RegIII beta and RegIII gamma, in colon tissue at steady state and in colitis; this was associated with changes in microbial composition and dysbiosis. Protein purification studies revealed that IL-17D bound not canonical IL-17 receptors, but rather CD93, a glycoprotein expressed on mature ILC3s. Mice lacking Cd93 in ILC3s exhibited impaired IL-22 production and aggravated colonic inflammation in experimental colitis. Thus, an IL-17D-CD93 axis regulates ILC3 function to preserve intestinal homeostasis.